Clinical utility of random anti-tumour necrosis factor drug testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritis. (2015)
Attributed to:
Infrastructure for collaboration: Leeds MRC Medical Bioinformatics Centre
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(15)60363-4
PubMed Identifier: 26312870
Publication URI: http://europepmc.org/abstract/MED/26312870
Type: Journal Article/Review
Volume: 385 Suppl 1
Parent Publication: Lancet (London, England)
ISSN: 0140-6736